1. Home
  2. HQY vs CRL Comparison

HQY vs CRL Comparison

Compare HQY & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HQY
  • CRL
  • Stock Information
  • Founded
  • HQY 2002
  • CRL 1947
  • Country
  • HQY United States
  • CRL United States
  • Employees
  • HQY 3120
  • CRL N/A
  • Industry
  • HQY Business Services
  • CRL Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • HQY Consumer Discretionary
  • CRL Health Care
  • Exchange
  • HQY Nasdaq
  • CRL Nasdaq
  • Market Cap
  • HQY 8.1B
  • CRL 7.3B
  • IPO Year
  • HQY 2014
  • CRL 2000
  • Fundamental
  • Price
  • HQY $92.95
  • CRL $179.11
  • Analyst Decision
  • HQY Strong Buy
  • CRL Buy
  • Analyst Count
  • HQY 15
  • CRL 16
  • Target Price
  • HQY $119.93
  • CRL $190.86
  • AVG Volume (30 Days)
  • HQY 824.0K
  • CRL 1.0M
  • Earning Date
  • HQY 12-08-2025
  • CRL 11-05-2025
  • Dividend Yield
  • HQY N/A
  • CRL N/A
  • EPS Growth
  • HQY 37.24
  • CRL N/A
  • EPS
  • HQY 1.65
  • CRL N/A
  • Revenue
  • HQY $1,268,928,000.00
  • CRL $4,028,615,000.00
  • Revenue This Year
  • HQY $10.27
  • CRL N/A
  • Revenue Next Year
  • HQY $8.24
  • CRL $2.43
  • P/E Ratio
  • HQY $56.46
  • CRL N/A
  • Revenue Growth
  • HQY 15.45
  • CRL N/A
  • 52 Week Low
  • HQY $74.07
  • CRL $91.86
  • 52 Week High
  • HQY $116.65
  • CRL $230.02
  • Technical
  • Relative Strength Index (RSI)
  • HQY 48.31
  • CRL 52.60
  • Support Level
  • HQY $93.35
  • CRL $175.58
  • Resistance Level
  • HQY $97.72
  • CRL $199.66
  • Average True Range (ATR)
  • HQY 2.61
  • CRL 6.52
  • MACD
  • HQY 0.08
  • CRL -0.41
  • Stochastic Oscillator
  • HQY 46.88
  • CRL 37.35

About HQY HealthEquity Inc.

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: